Indefinite Delivery Contract SPE2DR25D2109

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D2018 is a $999,999,999 single-award contract issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract's purpose is to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This...
The Indefinite Delivery Contract (IDC) SPE2DR25D2012 is a $999,999,999 single-award contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The IDC serves as a primary vehicle for DLA...
The Indefinite Delivery Contract (IDC) SPE2DR25D3016 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract serves to provide...
The Indefinite Delivery Contract (IDC) SPE2DR25D2007 is a single-award contract valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC is part of the DLA's Pharmaceutical Prime Vendor...
The Indefinite Delivery Contract (IDC) SPE2DR25D7910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2026 and is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and...
The Indefinite Delivery Contract (IDC) SPE2DU25D3130 is a single-award contract between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract covers a 30-month base period plus three 30-month option periods, through December 2036. The IDC aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including brand-name,...
The Indefinite Delivery Contract (IDC) SPE2DR25D3002 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across...
The Indefinite Delivery Contract (IDC) SPE2DR25D2208 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $999,999,999 contract has a performance period through December 2036 and serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities including...
The Indefinite Delivery Contract (IDC) SPE2DR25D1104 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a $9,999,999,999 ceiling value and runs through December 31, 2036. It serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical...
The Indefinite Delivery Contract (IDC) SPE2DR25D2917 is a $999,999,999 single-award contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a base period of 30 months and three 30-month option periods, running through December 2036. The purpose of this IDC is to establish Pharmaceutical Prime Vendor (PPV) Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the...

The Indefinite Delivery Contract (IDC) SPE2DR25D2109 is a $999,999,999 contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.

This IDC serves as a primary vehicle for providing these critical medical commodities to support military healthcare programs globally. It encompasses a 30-month base period with three 30-month option periods, and the contract is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition strategy. The PPV-G GEN V solicitation aims to establish multiple regional prime vendor contracts to ensure a diversified and resilient supply of pharmaceuticals for the Department of Defense, United States Coast Guard, and other government agencies, both for normal operations and contingency support. The contract was awarded on a Lowest Price Technically Acceptable (LPTA) basis, with the intention to use a reverse auction process to obtain the best distribution fees.

Generated 6/6/25, 9:43 AM